BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7954393)

  • 41. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.
    Kramm CM; Rainov NG; Sena-Esteves M; Chase M; Pechan PA; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Feb; 7(3):291-300. PubMed ID: 8835217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.
    Miyatake S; Martuza RL; Rabkin SD
    Cancer Gene Ther; 1997; 4(4):222-8. PubMed ID: 9253507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments.
    Coll JL; Mesnil M; Lefebvre MF; Lancon A; Favrot MC
    Gene Ther; 1997 Nov; 4(11):1160-6. PubMed ID: 9425438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
    Cool V; Pirotte B; Gérard C; Dargent JL; Baudson N; Levivier M; Goldman S; Hildebrand J; Brotchi J; Velu T
    Hum Gene Ther; 1996 Mar; 7(5):627-35. PubMed ID: 8845388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
    Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
    Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.
    Cowsill C; Southgate TD; Morrissey G; Dewey RA; Morelli AE; Maleniak TC; Forrest Z; Klatzmann D; Wilkinson GW; Löwenstein PR; Castro MG
    Gene Ther; 2000 Apr; 7(8):679-85. PubMed ID: 10800091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
    J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death.
    Calvez V; Rixe O; Wang P; Mouawad R; Soubrane C; Ghoumari A; Verola O; Khayat D; Colbère-Garapin F
    Clin Cancer Res; 1996 Jan; 2(1):47-51. PubMed ID: 9816089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D; Hardin J; Ray J; Gage FH
    J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
    Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
    Kramm CM; Rainov NG; Sena-Esteves M; Barnett FH; Chase M; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Oct; 7(16):1989-94. PubMed ID: 8930659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy.
    Izquierdo M; Cortés M; de Felipe P; Martín V; Díez-Guerra J; Talavera A; Perez-Higueras A
    Gene Ther; 1995 Jan; 2(1):66-9. PubMed ID: 7712334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging.
    Namba H; Iwadate Y; Tagawa M; Kimura M; Shimizu H; Sato Y; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1996 Oct; 7(15):1847-52. PubMed ID: 8894676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.